Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ICOS Corporation -- Ignore unavailable to you. Want to Upgrade?

To: SemiBull who wrote (995)	6/26/2003 8:33:41 PM
From: SemiBull	Read Replies (1) \| Respond to of 1139

Lilly CEO: Still Sees FDA Cialis Approval In 2nd Half 2003 Thursday June 26, 2:04 pm ET Taurel reiterated that Lilly still expects the FDA to approve its much anticipated erectile dysfunction drug Cialis in the second half of the year. "We stand by that basic statement, but have no guarantee that it won't slip into next year," he said. The drug is already available in Europe and competes against Pfizer Inc.'s Viagra and another new drug also awaiting FDA approval, called Levitra, which is sold by Bayer AG and GlaxoSmithKline PLC . -Hollister H. Hovey, Dow Jones Newswires, 201-938-5287; hollister.hovey@dowjones.com